JOURNAL ARTICLE
REVIEW
Add like
Add dislike
Add to saved papers

Choledochal cyst.

Since 1959 when Alonzo-Lej and colleagues introduced the modern era of treatment of choledochal cysts, much information has come to light, particularly from Japan where the incidence of choledochal cyst is much higher than in occidental countries. While the original classification of Alonzo-Lej is still in use, additional forms of the anomaly have been identified by modern imaging techniques. Antenatal ultrasound studies and accurate cholangiography have made it possible not only to better define these anomalies but also to provide information regarding etiology. It seems most likely that choledochal cysts are the result of pancreatic reflux into the biliary tree from an anomalous junction of the main pancreatic duct with the common bile duct. Ultrasound, radioscintigraphic studies, and various forms of cholangiography have made the diagnosis straightforward. Although many approaches to treatment have been tried over the years, the most successful approach is total cyst excision with Roux-en-Y hepaticojejunostomy. This provides excellent long-term results with minimal complications. Nonetheless, lifelong follow-up is necessary to avoid potential problems such as biliary cirrhosis. Other forms of choledochal cysts, such as choledochocele and Caroli's disease, are treated as the anatomy dictates and these individuals must be followed long term as well. The overall results are most gratifying.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app